Higher hospital costs and lengths of stay associated with quinolone-resistant Salmonella enterica infections in Hong Kong

Journal of Public Health

Volumn 32, Issue 2, 2010, Pages 165-172

  Broughton, Edward I ^a,c   Ip, Margaret ^b   Coles, Christian L ^c   Walker, Damian G ^c  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Costs; Fluoroquinolone; Hospitalization; Quinolone; Resistance; Salmonella

Indexed keywords

QUINOLONE DERIVATIVE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CHILD; COMORBIDITY; ECONOMICS; FEMALE; HONG KONG; HOSPITAL COST; HUMAN; INFANT; LENGTH OF STAY; MALE; MIDDLE AGED; PRESCHOOL CHILD; PREVALENCE; PROPORTIONAL HAZARDS MODEL; SALMONELLA ENTERICA; SALMONELLOSIS;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; COMORBIDITY; DRUG RESISTANCE, BACTERIAL; FEMALE; HONG KONG; HOSPITAL COSTS; HUMANS; INFANT; LENGTH OF STAY; MALE; MIDDLE AGED; PREVALENCE; PROPORTIONAL HAZARDS MODELS; QUINOLONES; SALMONELLA ENTERICA; SALMONELLA INFECTIONS;

EID: 77953008760     PISSN: 17413842     EISSN: 17413850     Source Type: Journal    
DOI: 10.1093/pubmed/fdp057     Document Type: Article

References (43)

1. WHO: Drug resistant Salmonella. In Fact Sheet No 139. Edited by Food Safety Department; 2008. http://www.who.int/mediacentre/factsheets/ fs139/en/print.html (10 December 2008, date last accessed).
2. Ashtiani MT, Monajemzadeh M, Kashi L. Trends in antimicrobial resistance of fecal shigella and Salmonella isolates in Tehran, Iran. Indian J Pathol Microbiol 2009;52(1):52-55
3. Lauderdale TL, Aarestrup FM, Chen PC et al. Multidrug resistance among different serotypes of clinical Salmonella isolates in Taiwan. Diagn Microbiol Infect Dis 2006;55(2):149-155
4. Kumar S, Rizvi M, Berry N. Rising prevalence of enteric fever due to multidrug-resistant Salmonella: an epidemiological study. J Med Microbiol 2008;57(Pt 10):1247-1250
5. Morley PS, Apley MD, Besser TE et al. Antimicrobial drug use in veterinary medicine. J Vet Intern Med 2005;19(4):617-629
6. Parry CM, Threlfall EJ. Antimicrobial resistance in typhoidal and nontyphoidal salmonellae. Curr Opin Infect Dis 2008;21(5):531-538
7. Martin LJ, Fyfe M, Dore K et al. Increased burden of illness associated with antimicrobial-resistant Salmonella enterica serotype typhimurium infections. J Infect Dis 2004;189(3):377-384
8. Fisk TL, Lundberg BE, Guest JL et al. Invasive infection with multidrug-resistant Salmonella enterica serotype typhimurium definitive type 104 among HIV-infected adults. Clin Infect Dis 2005;40(7):1016-1021
9. Varma JK, Molbak K, Barrett TJ et al. Antimicrobial-resistant nontyphoidal Salmonella is associated with excess bloodstream infections and hospitalizations. J Infect Dis 2005;191(4):554-561
10. Lee LA, Puhr ND, Maloney EK et al. Increase in antimicrobialresistant Salmonella infections in the United States, 1989-1990. J Infect Dis 1994;170(1):128-134
11. Helms M, Vastrup P, Gerner-Smidt P et al. Excess mortality associated with antimicrobial drug-resistant Salmonella typhimurium. Emerg Infect Dis 2002;8(5):490-495
12. Ng CK, Wu TC, Chan WM et al. Clinical and economic impact of an antibiotics stewardship programme in a regional hospital in Hong Kong. Qual Saf Health Care 2008;17(5):387-392
13. Hospital Authority of Hong Kong. Hospital Authority Ordinance: List of Charges. Volume Chapter 113 section 18(1) and 18(2). 2003.
14. Benchmark currency rates. http://www.bloomberg.com/markets/ currencies/fxc.html (27 January 2009, date last accessed).
15. Charlson ME, Pompei P, Ales KL et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40(5):373-383
16. Hall WH, Ramachandran R, Narayan S et al. An electronic application for rapidly calculating Charlson comorbidity score. BMC Cancer 2004;4:94.
17. Clinical and Laboratory Standards Institute (ed.). Performance Standards for Antimicrobial Susceptibility Testing. Volume M100-S18. 18th Supplement edn. Wayne, Pennsylvania: CLSI, 2008.
18. Crump JA, Barrett TJ, Nelson JT et al. Reevaluating fluoroquinolone breakpoints for Salmonella enterica serotype Typhi and for non-Typhi salmonellae. Clin Infect Dis 2003;37(1):75-81.
19. Slinger R, Desjardins M, McCarthy AE et al. Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series. BMC Infect Dis 2004;4:36.
20. Cooke FJ, Day M, Wain J et al. Cases of typhoid fever imported into England, Scotland and Wales (2000-2003). Trans R Soc Trop Med Hyg 2007;101(4):398-404.
21. Crump JA, Kretsinger K, Gay K et al. Clinical response and outcome of infection with Salmonella enterica serotype Typhi with decreased susceptibility to fluoroquinolones: a United States foodnet multicenter retrospective cohort study. Antimicrob Agents Chemother 2008;52(4):1278-1284
22. Weir EK, Martin LC, Poppe C et al. Subinhibitory concentrations of tetracycline affect virulence gene expression in a multi-resistant Salmonella enterica subsp. enterica serovar Typhimurium DT104. Microbes Infect 2008;10(8):901-907
23. Diarrassouba F, Diarra MS, Bach S et al. Antibiotic resistance and virulence genes in commensal Escherichia coli and Salmonella isolates from commercial broiler chicken farms. J Food Prot 2007;70(6): 1316-1327
24. Nde CW, Logue CM. Characterization of antimicrobial susceptibility and virulence genes of Salmonella serovars collected at a commercial turkey processing plant. J Appl Microbiol 2008;104(1): 215-223
25. Molbak K. Human health consequences of antimicrobial drug-resistant Salmonella and other foodborne pathogens. Clin Infect Dis 2005;41(11):1613-1620
26. Buckley AM, Webber MA, Cooles S et al. The AcrAB-TolC efflux system of Salmonella enterica serovar Typhimurium plays a role in pathogenesis. Cell Microbiol 2006;8(5):847-856
27. Virlogeux-Payant I, Baucheron S, Pelet J et al. TolC, but not AcrB, is involved in the invasiveness of multidrug-resistant Salmonella enterica serovar Typhimurium by increasing type III secretion system-1 expression. Int J Med Microbiol 2008;298(7-8):561-569
28. Dryden MS, Gabb RJ, Wright SK. Empirical treatment of severe acute community-acquired gastroenteritis with ciprofloxacin. Clin Infect Dis 1996;22(6):1019-1025
29. Leibovitz E, Janco J, Piglansky L et al. Oral ciprofloxacin vs. intramuscular ceftriaxone as empiric treatment of acute invasive diarrhea in children. Pediatr Infect Dis J 2000;19(11):1060-1067
30. Lin TY, Chiu CH, Lin PY et al. Short-term ceftriaxone therapy for treatment of severe non-typhoidal Salmonella enterocolitis. Acta Paediatr 2003;92(5):537-540
31. Moolasart P, Eampokalap B, Ratanasrithong M. Comparison of the efficacy of ceftibuten and norfloxacin in the treatment of acute gastrointestinal infection in children. Southeast Asian J Trop Med Public Health 1999;30(4):764-769
32. Sieper J, Fendler C, Laitko S et al. No benefit of long-term ciprofloxacin treatment in patients with reactive arthritis and undifferentiated oligoarthritis: a three-month, multicenter, double-blind, randomized, placebo-controlled study. Arthritis Rheum 1999;42(7):1386-1396
33. Cui S, Li J, Sun Z et al. Characterization of Salmonella enterica isolates from infants and toddlers in Wuhan, China. J Antimicrob Chemother 2009;63(1):87-94.
34. Hsu RB, Chen RJ, Lin FY et al. Influence of ciprofloxacin resistance on risk factors for endovascular infection in patients with infection due to group C nontyphoid salmonellae. Clin Infect Dis 2005;40(9):1364-1367
35. Meakins S, Fisher IS, Berghold C et al. Antimicrobial drug resistance in human nontyphoidal Salmonella isolates in Europe 2000- 2004: a report from the Enter-net International Surveillance Network. Microb Drug Resist 2008;14(1):31-35
36. Murray SB, Bates DW, Ngo L et al. Charlson Index is associated with one-year mortality in emergency department patients with suspected infection. Acad Emerg Med 2006;13(5):530-536 (Pubitemid 44316644)
37. McGregor JC, Kim PW, Perencevich EN et al. Utility of the Chronic Disease Score and Charlson Comorbidity Index as comorbidity measures for use in epidemiologic studies of antibiotic-resistant organisms. Am J Epidemiol 2005;161(5):483-493
38. Lee SC, Yang PH, Shieh WB et al. Bacteremia due to non-typhi Salmonella: analysis of 64 cases and review. Clin Infect Dis 1994;19(4):693-696
39. Holmberg SD, Solomon SL, Blake PA. Health and economic impacts of antimicrobial resistance. Rev Infect Dis 1987;9(6):1065-1078
40. Holmberg SD, Wells JG, Cohen ML. Animal-to-man transmission of antimicrobial-resistant Salmonella: investigations of U.S. outbreaks, 1971-1983. Science 1984;225(4664):833-835
41. Weinberger M, Andorn N, Agmon V et al. Blood invasiveness of Salmonella enterica as a function of age and serotype. Epidemiol Infect 2004;1:1023-1028
42. Jones TF, Ingram LA, Cieslak PR et al. Salmonellosis outcomes differ substantially by serotype. J Infect Dis 2008;198(1):109-114
43. Foley SL, Lynne AM. Food animal-associated Salmonella challenges: pathogenicity and antimicrobial resistance. J Anim Sci 2008; 86(14 Suppl):E173-87.